Aktis Oncology AKTS
NASDAQ AKTS
$16.62 +0.34 (+2.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Aktis Oncology (AKTS) Shares Outstanding (2025 - 2026)

Updated

Aktis Oncology (AKTS) posted Weighted Average Shares Outstanding of 55.65 million for Q3 2026, compared with 809,765 a year earlier and up 0.6% from the prior quarter.

Analysis

Aktis Oncology (AKTS) Shares Outstanding (2025 - 2026) Analysis & Trends

For FY2025, Aktis Oncology's Weighted Average Shares Outstanding came in at 809,765.

  • According to Business Quant data, Weighted Average Shares Outstanding for the three prior quarters was 55.3 million (Q2 2026), 48.63 million (Q1 2026) and 809,765 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.41 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 1.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 1.94 Bn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.55 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.24 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 5.70 Bn
10 Aktis Oncology 895.95 Mn 335.72 Mn - 55.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 55.65 Mn
Jun 30, 2026 55.30 Mn
Mar 31, 2026 48.63 Mn
Dec 31, 2025 807,281.00
Jun 30, 2025 807,281.00
Mar 31, 2025 805,821.00
API Access

Aktis Oncology Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=AKTS&period=max&api_key=YOUR_API_KEY